Barriers and Support-System while Considering Hematopoietic Stem Cell Transplant (HSCT): A Qualitative Study of Pre-HSCT Acute Leukemia Patients from a Standalone Transplant Laboratory in India

Author:

Solanki Hina12,Tiwari Aseem K.3,Vashisht Naveen1,Raina Vimarsh1,Sharma Girish24

Affiliation:

1. Chimera Transplant Research Foundation, South Extension Part-II, Masjid Moth, New Delhi, India

2. Centre for Medical Biotechnology, Amity Institute of Biotechnology, Amity University Uttar Pradesh, Noida, India

3. Department of Transfusion Medicine, Medanta The Medicity, Gurgaon, Haryana, India

4. Amity Center for Cancer Epidemiology & Cancer Research, Amity University Uttar Pradesh, Noida, India

Abstract

Abstract Introduction Hematopoietic stem cell transplant (HSCT) is the definite treatment for acute leukemia but considering HSCT is challenging for the patients. There are many studies that have described the patients’ experience after HSCT but very few studies have reported their experience before going for HSCT and there is no published report in India on patients’ experience before HSCT. Objective We conducted a qualitative study to understand barriers, and support-system while considering HSCT and the chances of getting matched unrelated donor (MUD) for these patients. Materials and Methods The present study was a qualitative study. Demographic details of 514 patients who consented for the study were noted and the patients and their families were interviewed using a semistructured interview booklet before HSCT. The interview sessions were recorded, transcribed verbatim, and analyzed for emerging themes. The study data were analyzed using QDA Miner Lite 4.0 software (Provalis Research, Montreal, Canada). Descriptive statistics such as frequency and percentage were used. The chances of getting a human leukocyte antigen (HLA)-matched donor were also computed by “HLA-matching software.” Results Acute myeloid leukemia (64.01%) was commoner than acute lymphoid leukemia (35.99%) with male: female ratio as 1.98:1. The study showed nine themes as barriers and six themes emerged in regard to the support system for HSCT decision making. The biggest barriers identified among these patients pre-HSCT were related to cost, probability of “success of transplant,” and probable “quality of life.” The family support was the biggest support system variable followed by “treating doctor.” The chances of getting a MUD for these patients were 13.22% and 5.44% in global and Indian data pool, respectively. Conclusion Deciding upon HSCT can be challenging for patients and understanding of barriers and support-system variables among these patients would provide important insights and help design better counseling techniques for such patients of HSCT and future studies in this context.

Publisher

Georg Thieme Verlag KG

Subject

Oncology,Pediatrics, Perinatology, and Child Health

Reference17 articles.

1. Allogeneic stem cell transplantation: a historical and scientific overview;A K Singh;Cancer Res,2016

2. Cost of hematopoietic stem cell transplantation in India;S K Sharma;Mediterr J Hematol Infect Dis,2014

3. Andrykowski, Richard P. Psychosocial issues in hematopoietic cell transplantation. In: Thomas ED, Forman SJ, Appelbaum FR, Blume KG, eds.;A Michael;Thomas, hematopoietic cell transplantation. 3rd ed. Blackwell,2004

4. Psychological factors and survival after bone marrow transplantation in patients with leukemia;R Akaho;Psychiatry Clin Neurosci,2003

5. The influence of health insurance on outcomes of related-donor hematopoietic stem cell transplantation for AML and CML;G B Selby;Biol Blood Marrow Transplant,2001

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3